Baicalein

Baicalein

SCHEMBL3430203

O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12.ON1CCCC1

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 7/20 0.78
PTPRS Q13332 5/20 0.78
CREB1 P16220 5/20 0.78
CYP1A1 P04798 4/20 0.78
KMT2A Q03164 4/20 0.78
CYP1B1 Q16678 4/20 0.78
FTO Q9C0B1 4/20 0.78
MAPT P10636 4/20 0.78
GABRP O00591 3/20 0.78
GABRD O14764 3/20 0.78
GABRA1 P14867 3/20 0.78
GABRB1 P18505 3/20 0.78
GABRG2 P18507 3/20 0.78
GABRB3 P28472 3/20 0.78
GABRA5 P31644 3/20 0.78
GABRA3 P34903 3/20 0.78
GABRA2 P47869 3/20 0.78
GABRB2 P47870 3/20 0.78
GABRA4 P48169 3/20 0.78
GABRE P78334 3/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Baicalein SCHEMBL3414954 0.99 ABCB1 (0.76) ABCB1PTPRSCREB1CYP1A1KMT2A
Baicalein SCHEMBL29385549 0.88 ABCB1 (1.00) ABCB1PTPRSCREB1CYP1A1KMT2A
Baicalein SCHEMBL139617 0.88 ABCB1 (1.00) ABCB1PTPRSCREB1CYP1A1KMT2A
Baicalein SCHEMBL5695785 0.88 ABCB1 (1.00) ABCB1PTPRSCREB1CYP1A1KMT2A
Baicalein SCHEMBL28206740 0.87 ABCB1 (0.97) ABCB1PTPRSCREB1CYP1A1KMT2A
Baicalein SCHEMBL28630648 0.87 ABCB1 (0.97) ABCB1PTPRSCREB1CYP1A1KMT2A
Baicalein SCHEMBL28087999 0.87 ABCB1 (0.97) ABCB1PTPRSCREB1CYP1A1KMT2A
Baicalein SCHEMBL28372093 0.87 ABCB1 (0.97) ABCB1PTPRSCREB1CYP1A1KMT2A
Baicalein SCHEMBL28826034 0.87 ABCB1 (0.97) ABCB1PTPRSCREB1CYP1A1KMT2A
Baicalein SCHEMBL28198926 0.87 ABCB1 (0.97) ABCB1PTPRSCREB1CYP1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8377895-B2 Cyclin-dependent protein kinases inhibitors of Scutellaria flavonoid organic amine derivatives, synthesis and use thereof ZHANG SHIXUAN (CN) 2013-02-19 US disclosed
US-20100197619-A1 CYCLIN-DEPENDENT PROTEIN KINASES INHIBITORS OF SCUTELLARIA FLAVONOID ORGANIC AMINE DERIVATIVES, SYNTHESIS AND USE THEREOF ZHANG SHIXUAN 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197619-A1 CYCLIN-DEPENDENT PROTEIN KINASES INHIBITORS OF SCUTELLARIA FLAVONOID ORGANIC AMINE DERIVATIVES, SYNTHESIS AND USE THEREOF CCNI, CDK1, CCNL2 ABCB1 999/4885PTPRS 4199/4885CREB1 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.